VIA Pharmaceuticals, Inc.

OTCPK:VIAP Stock Report

Market Cap: US$20.0

VIA Pharmaceuticals Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure17.4yrs

Recent management updates

No updates

Recent updates

No updates

CEO

VIA Pharmaceuticals has no CEO, or we have no data on them.

Board Members

NamePositionTenureCompensationOwnership
Thomas Quertermous
Chief Scientific Officer & Member of Scientific Advisory Boardno datano datano data
Frederick Craves
Director17.4yrsno datano data
David Howard
Independent Director17.4yrsUS$38.50kno data
John Larson
Director21.8yrsUS$25.00kno data
Jean Tardif
Member of Clinical Advisory Boardno datano datano data
Peter Libby
Member of Clinical Advisory Boardno datano datano data
Christopher Glass
Scientific Advisorno datano datano data
Jean-Lucien Rouleau
Member of Clinical Advisory Boardno datano datano data
Colin Funk
Scientific Advisorno datano datano data
Marc Pfeffer
Chair of Clinical Advisory Boardno datano datano data
Israel Charo
Scientific Advisorno datano datano data
Robert Fenichel
Member of Clinical Advisory Boardno datano datano data

17.4yrs

Average Tenure

74yo

Average Age

Experienced Board: VIAP's board of directors are seasoned and experienced ( 17.4 years average tenure).